But Byetta has been almost too successful.
The bad news is that Lilly, which distributes Byetta along with Amylin, doesn’t want new patients to start on Byetta right now. They can’t make the pens that Byetta comes in fast enough. Lilly has “asked physicians to temporarily suspend the start of new patients on Byetta until supply and inventory levels are restored.”
Consequently, I almost feel that I am being mean by talking up something that you might not be able to get right now. But my recommendation is to be patient. It’s worth it.
My Byetta Progress Report
< Previous 1 | Page 2 >
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
